Fredun Pharmaceuticals Announces 2:1 Bonus Issue, Signaling Strong Growth Confidence
Mumbai (Maharashtra) [India], May 26: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of the leading pharmaceutical formulation manufacturing companies in India, diversified across generics, cosmeceuticals, nutraceuticals, mobility, and animal healthcare products, has announced a 2:1 bonus issue of equity shares, underscoring its strong financial performance and continued confidence in future growth. The Board of Directors, […]
Continue Reading